Trial Profile
A Rollover Protocol to Provide Subjects From Taiwan Continued Access to Tenofovir Disoproxil Fumarate After Completing Study GS-US-174-0108 [EXTENSION OF 700013822]
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Apr 2014
Price :
$35
*
At a glance
- Drugs Tenofovir disoproxil fumarate (Primary)
- Indications Hepatitis B
- Focus Adverse reactions
- Sponsors Gilead Sciences
- 28 Feb 2014 Status changed from active, no longer recruiting to completed as reported by Clinicaltrials.gov record.
- 31 Aug 2013 New trial record